Catalyst

Slingshot members are tracking this event:

FDA rejects Acacia Pharma's amisulpride for postoperative nausea and vomiting

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
CARA

100%
ACPH.BR

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 08, 2018
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Amisulpride, Postoperative Nausea, Vomiting, Cr845